Abstract
Free full text
A river runs through it: how autophagy, senescence, and phagocytosis could be linked to phospholipase D by Wnt signaling
Abstract
Neutrophils and macrophages are professional phagocytic cells, extremely efficient at the process of engulfing and killing bacteria. Autophagy is a similar process, by which phagosomes recycle internal cell structures during nutrient shortages. Some pathogens are able to subvert the autophagy process, funneling nutrients for their own use and for the host's detriment. Additionally, a failure to mount an efficient autophagy is a deviation on the cell's part from normal cellular function into cell senescence and cessation of the cell cycle. In spite of these reasons, the mechanism of autophagy and senescence in leukocytes has been under studied. We advance here the concept of a common thread underlying both autophagy and senescence, which implicates PLD. Such a PLD-based autophagy mechanism would involve two positive inputs: the generation of PA to help the initiation of the autophagosome and a protein–protein interaction between PLD and PKC that leads to enhanced PA. One negative input is also involved in this process: down-regulation of PLD gene expression by mTOR. Additionally, a dual positive/negative input plays a role in PLD-mediated autophagy, β-catenin increase of autophagy through PLD up-regulation, and a subsequent feedback termination by Dvl degradation in case of excessive autophagy. An abnormal PLD-mTOR-PKC-β-catenin/Wnt network function could lead to faulty autophagy and a means for opportunistic pathogens to survive inside of the cell.
Introduction
The innate immune system is a complex system, through which macrophages, dendritic cells, and neutrophils respond to pathogens. The way by which neutrophils and macrophages engulf and respond to foreign pathogens is a subject of great interest in cell biology [1]. However, the manners by which the cells survive, and a pathogen persists inside of the cell are subjects of continued interest in chronic inflammation. Autophagy is a process, wherein phagosomes digest and degrade cellular refuse and allow for the recycling of macromolecules [2, 3]. Autophagy becomes truly necessary during cellular survival, particularly in conditions of starvation or stress [4]. Similarly, the intimate role of autophagy with cell survival is of great interest in cell biology, yet its relevance to leukocytes has remained under studied. An involvement of membrane dynamics in autophagy is shared with other key leukocyte functions, such as phagocytosis. Hence, it seems likely that these two functions—autophagy and leukocytic engulfment—could be related by similar underlying mechanisms, a concept advanced by Mitroulis et al. [5].
Autophagy is a process wherein phagosomes digest and degrade cellular refuse and allow for the recycling of macromolecules. Autophagy becomes truly necessary during cellular survival, particularly in conditions of starvation or stress. The double membranes of phagosomes sequester cellular debris derived from various other cellular components, such as the plasma membrane and the Golgi body or as proteins and lipids are reused/recycled, in a specific or fixed location within the cell (Fig. 1). Furthermore, autophagy has been linked to the development of leukemia [6]. Its role in this pathology has been somewhat under studied.
In approaching autophagy in leukocytes, it is pertinent to examine relationships that already exist in the cell, which could possibly mimic or act similarly in function to autophagy, such as cell survival. A prominent protein in the cell-survival mechanism is PLD and its enzymatic reaction product, PA. The rapid generation of PA and the protein–protein interactions of PLD are the two main ways through which PLD exerts its control over cellular functions [7,–9]. The mammalian PLD2 isoform can lead to cytoskeleton organization through a variety of effectors, such as S6K, actin, Rac2, and WASp [10, 11], while up-regulating leukocyte chemotaxis [12, 13]. PLD2 has actually two different enzymatic activities—lipase and guanine nucleotide exchange factor—the latter acts upon small GTPases of the cellular motility machinery, such as Rac and Rho [14,–16]. PLD is under expression control by mTOR [17], and mTOR is a key component of autophagy [18]. Furthermore, a link between PLD2 expression and β-catenin (the latter also being important in autophagy) has been established [19].
Based on this previous study, we propose that PLD2 and its reaction product PA are at the center of a cell-signaling network that interacts with PKC, mTOR, and β-catenin-Wnt. We further propose that this interaction is needed during autophagy and contributes to cell survival in leukocytes and that disruption of such an interaction could lead to inadequate leukocyte functionality (Fig. 2).
A FOUR-PRONGED ROLE OF PLD IN AUTOPHAGY
The proposal stated above, which could account for the formation and maintenance of the autophagosomes, is dissected into four different categories (Fig. 2), as follows:
PLD-generated PA participates in the formation of the initial autophagosome.
There is interplay between phospholipids and a PLD2-PKC interaction that leads to enhanced autophagy.
mTOR down-regulates PLD gene expression and suppresses autophagy.
The Wnt/β-catenin pathway interacts with PLD in a dual context.
We will elaborate further on these four possibilities now and present the rationale of why PLD is important to autophagy in uncompromised and fully functioning leukocytes.
PLD-generated PA participates in the formation of the initial autophagosome
The formation of the isolation membrane is the earliest event in autophagosome generation. PLD2 could play a key role through the regulation of the generation of PA pools, which have been shown to regulate positively formation of autophagosomes [20]. Additionally, it has been shown that PLD2 influences the curvature of membranes through PA [21]. This fact, in particular, has the potential to promote autophagy, as negative curvature is an element that can lead to fusion of lipids, which indeed promotes the formation of the initial autophagosome [22].
We suggest that PLD will also lead to the reuptake of plasma membranes via endocytosis, leading to precursors of the autophagosomes. PLD2 also has been shown to localize on the edges of the Golgi apparatus, indicating a role in cellular trafficking [23]. This could be accomplished through membrane modeling, recycling membranes into autophagosomes, and subsequently, consuming cell debris. Overall, this pathway may be vital in understanding autophagy in the context of chronic inflammation and leukocytes, especially given that phagocytosis and autophagy share similar mechanisms in leukocytes [24].
There are several possible connections between autophagy and phospholipids other than PA. Lipid metabolism and the small G protein Arf6, which is involved in autophagosome formation, directly target PLD [25]. Additionally, Arf6 is a stimulator of β-catenin-induced transcriptional activity [26]. This could establish an additional feedback loop with PLD2. Inhibition of DAG kinase induces autophagy, mainly because the lack of this kinase is compensated by an increase of PLD so that homeostasis of PA is maintained in the cell [22, 27]. Inducers of phagocytosis, are known to be activators of PLD2 [10] and are responsible for triggering autophagy, meaning that PLD could possibly do this by direct regulation of phospholipid generation and by signaling through other means, such as PKC involvement. Thus, an underlying mechanism for autophagy could exist through PLD.
There is interplay between phospholipids and a PLD2-PKC interaction that leads to enhanced autophagy
One of the key regulators of PLD2 is PKC, and PKC-ε binds to DAG and influences phagosome formation [28]. PKC accumulation also decreases at nascent phagosomes [28]. This event likely leads to a decrease in PLD2 phosphorylation, as PLD2 is located at the phagosomes [29]. Loss of PLD2 phosphorylation reduces enzymatic activity [30], affecting autophagy [31]. Furthermore, it has been shown that there are two distinct pools of PKC that are generated in the cell. One that is mediated by phosphatidylinositol (4,5) bisphosphate-derived DAG, which is generated in the nucleus and yields a selective translocation of PKC-βII and another that is mediated by PLD2-mediated DAG generation that results in nuclear localization of PKC-α [32]. PKC can then be thought of as balancing the autophagy process by initially activating/phosphorylating the PLD2-mediated portion of this process and then subsequently, negatively regulating PLD2 and its downstream signaling products after phagosome formation is complete. The ability of PLD2 to function as a peripheral membrane protein allows for its fast access to nascent phagosomes, and our laboratory has shown that it can interact with a wide variety of other players that regulate cytoskeletal behavior, such as WASp [10].
Furthermore, PKC is an important part of autophagy regulation, specifically during PA-mediated autophagosome formation. It is likely that PKC could regulate leukocyte autophagy, especially given the close association of PLD2 with it. This is a potentially vital thread in the relatively unknown path of leukocyte autophagy, which will necessitate further study.
mTOR down-regulates PLD gene expression and suppresses autophagy
PLD2 interacts with mTOR [17], which is a well-known negative regulator of autophagy [33]. Activated mTOR is associated with a nutrient-rich environment that the cell uses for division and growth. mTOR participates in a multipronged approach in delaying autophagy, as it has been shown to phosphorylate Unc51-like kinase 1 and inhibit autophagosome formation and autophagy and promote growth of cells [18]. As it has been reported that ectopic expression of mTOR and S6K abrogate PLD2 gene expression [17], it follows that mTOR not only prevents autophagy by the standard method but also by depriving the cell of PLD and PA, both of which could augment this capability. Not only does mTOR exert negative feedback on autophagy, but it is also part of the inflammasome [34]. Thus, mTOR and PLD are linked together during this process, as indicated in Fig. 2.
The Wnt/β-catenin pathway interacts with PLD in a dual context
We propose that PLD2 is a downstream effector in the Wnt pathway with PLD2 inhibiting Wnt, and Wnt is an integral protein to the Wnt/β-catenin signaling pathway, which regulates gene expression and actin anchoring [35, 36], whereas the disruption of this pathway leads to senescence [19, 37]. Wnt acts by binding a frizzled receptor on the surface of the cell, which alters its conformation to a Dvl, which is directly responsible for controlling the amount of β-catenin that is generated and reaches the nucleus. Wnt/β-catenin controls several transcription factors, and as reported in ref. [19], β-catenin is able to up-regulate PLD2 gene expression in some cases. Such elevated PLD2 expression could result in an enhanced capability of the cell to initiate autophagy and delay senescence, as indicated in Fig. 2. However, a second scenario should be considered that could impact leukocyte homeostasis, which is overstimulation of the autophagy pathway, and that leads to impaired leukocyte physiology via enhanced or up-regulated autophagy (Fig. 3). To this, PLD2 would serve as a canonical negative-feedback mechanism, which would bring down β-catenin levels and prevent overstimulation of the autophagy pathway. Following PLD2-mediated up-regulation of autophagosome formation and autophagy completion, PLD2 or components involved in autophagy could down-regulate Wnt via degradation of the Dvl [38].
In these two scenarios described thus far, the role of PLD in the pathway would involve its own regulation by the pathway and its ability to regulate components of the same pathway. By ascertaining how the Wnt pathway partners with PLD2 during autophagy, we can begin to develop intermediate maps that can be used to elucidate further leukocyte autophagy regulation, and the components of autophagy that are associated with Wnt down-regulation can be examined to see where and when the Dvl is degraded and why PLD2 overexpression does not correct itself by degrading Dvl. This will allow the establishment of important targets to enhance (or possibly negate) autophagy in associated cell dysfunctions.
AUTOPHAGY, LEUKOCYTES, AND INTRACELLULAR PATHOGENS
Autophagy in leukocytes has been characterized as a unique process through which it also functions in the context of the innate immune response [39]. The involvement of mTOR during bacterial invasion and intracellular pathogen killing by neutrophils and macrophages has been shown [40]. In fact, several microbes have evolved sophisticated mechanisms to manipulate the mTOR pathway to their benefit and to the host's detriment [41, 42]. The intracellular killing of pathogens by neutrophils and macrophages and their contribution to the phagolysosome, as well as the subversion of the system by bacteria, are summarized in Fig. 4. Also, mTOR can disable turnover of metabolic waste through autophagy and disrupt PLD2-mediated survival signal generation. Its suppression of PLD2-mediated autophagy in leukocytes may lead to senescence and aberrant inflammation.
IF AUTOPHAGY DOES NOT FUNCTION WELL: SENESCENCE
One of the goals of cell survival is avoidance of senescence, which is the cessation of the cell cycle. An important aspect of failure to mount an efficient autophagy process is the deviation into cell senescence. The inability of PLD to stave off the effects of aging or even apoptosis stems from the accumulation of ceramide, which inhibits PLD and contributes to survival of a variety of cells [43,–45]. Leukocyte senescence has also been implicated as a cause of chronic inflammation, especially in patients with chronic obstructive pulmonary disease [46]. It stands to reason that the intimate association of PLD2 with cell survival and leukocyte physiology implicates a role for it in warding off senescence. The Wnt/β-catenin pathway up-regulates PLD2 expression, and Wnt down-regulation likens the probability of a cell entering senescence [47, 48]. Thus, senescence could be induced as a result of the Wnt-mediated loss of the survival signals of PLD2, as well as the loss of its ability to initiate and regulate autophagy.
An isoform of Wnt, Wnt5a, has been implicated to have anti-inflammatory effects on bronchial macrophages [49]. The Wnt pathway has many other proteins that interact with a variety of targets between the disheveled and β-catenin portions of the pathway. Previous studies have implied that the PLD proteins are controlled by Wnt signaling and that their expression is impacted by changes in the pathway [37]. We advance here the concept that PLD2 may have a key role in both Wnt-mediated changes in cell morphology and may also be involved in negatively regulating the Wnt pathway.
CONCLUSIONS
We have described several insights and perspectives on how autophagy, senescence, and phagocytosis could be linked to the Wnt pathway through PLD (which we have named “PLD-Wnt”). Wnt regulates PLD2 expression through β-catenin, and PLD2, in turn, regulates autophagy (and at the same time, phagocytosis, which has been shown to be intimately linked with autophagy), which keeps metabolic waste levels low and maintains cell survival and health. In cases where Wnt signaling is disrupted, PLD2 expression is down-regulated, leading to improper autophagy and cell deterioration. Aberrant autophagy could also be a starting point for a faulty innate immune response by phagocytes. Furthermore, Wnt can play a role in inflammation through overstimulation of PLD2, wherein autophagy provides a means for opportunistic pathogens to survive inside of the cell. Further study of this signaling PLD-Wnt pathway seems warranted.
ACKNOWLEDGMENTS
The following grants (to J.G-C.) have supported this work: HL056653-14 from the U.S. National Institutes of Health and 13GRNT17230097 from the American Heart Association.
Footnotes
- Arf6
- ADP-ribosylation factor 6
- DAG
- diacylglycerol
- Dvl
- disheveled receptor
- mTOR
- mammalian target of rapamycin
- PA
- phosphatidic acid
- PKC
- protein kinase C
- PLD
- phospholipase D
- Rac2
- hematopoietic cell-specific Rho family GTPase
- Rho
- 'Ras-like' proteins superfamily
- S6K
- S6 kinase
- WASp
- Wiskott-Aldrich syndrome protein
AUTHORSHIP
J.G-C. devised the idea of the manuscript, searched literature, prepared the figures, and wrote the paper. S.K. searched literature and wrote the paper.
REFERENCES
Articles from Journal of Leukocyte Biology are provided here courtesy of The Society for Leukocyte Biology
Full text links
Read article at publisher's site: https://doi.org/10.1189/jlb.2vmr0214-120rr
Read article for free, from open access legal sources, via Unpaywall: https://jlb.onlinelibrary.wiley.com/doi/pdfdirect/10.1189/jlb.2VMR0214-120RR
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1189/jlb.2vmr0214-120rr
Article citations
Network medicine framework identified drug-repurposing opportunities of pharmaco-active compounds of Angelica acutiloba (Siebold & Zucc.) Kitag. for skin aging.
Aging (Albany NY), 15(11):5144-5163, 12 Jun 2023
Cited by: 0 articles | PMID: 37310405 | PMCID: PMC10292898
Biocompatible Nano-Hydroxyapatites Regulate Macrophage Polarization.
Materials (Basel), 15(19):6986, 08 Oct 2022
Cited by: 3 articles | PMID: 36234325 | PMCID: PMC9573195
The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
Cell Commun Signal, 19(1):43, 08 Apr 2021
Cited by: 2 articles | PMID: 33832505 | PMCID: PMC8034102
Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis.
Am J Respir Crit Care Med, 203(6):707-717, 01 Mar 2021
Cited by: 144 articles | PMID: 32991815 | PMCID: PMC7958503
D-series Resolvins activate Phospholipase D in phagocytes during inflammation and resolution.
FASEB J, 34(12):15888-15906, 12 Oct 2020
Cited by: 7 articles | PMID: 33047359 | PMCID: PMC7686130
Go to all (15) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Ral isoforms are implicated in Fc gamma R-mediated phagocytosis: activation of phospholipase D by RalA.
J Immunol, 185(5):2942-2950, 02 Aug 2010
Cited by: 20 articles | PMID: 20679536
The role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney disease.
PLoS One, 8(8):e73173, 23 Aug 2013
Cited by: 15 articles | PMID: 24009738 | PMCID: PMC3751888
Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
PLoS One, 5(8):e12109, 12 Aug 2010
Cited by: 27 articles | PMID: 20711340 | PMCID: PMC2920823
HS1BP3 inhibits autophagy by regulation of PLD1.
Autophagy, 13(5):985-986, 25 Feb 2017
Cited by: 4 articles | PMID: 28318354 | PMCID: PMC5446074
Review Free full text in Europe PMC
Phospholipase D in cellular senescence.
Biochim Biophys Acta, 1439(2):291-298, 01 Jul 1999
Cited by: 37 articles | PMID: 10425402
Review
Funding
Funders who supported this work.
American Heart Association
NHLBI NIH HHS (3)
Grant ID: HL056653-14
Grant ID: R29 HL056653
Grant ID: R01 HL056653
U.S. National Institutes of Health (1)
Grant ID: 13GRNT17230097